Leeds spinout adsilico raises $13M Series A to test devices on virtual patients

adsilico is a University of Leeds spinout that builds AI-generated virtual patient populations for testing medical devices. PXN Ventures led the round, with Northern Gritstone and Parkwalk also joining. The amount was announced in pounds, and the dollar figure is a Lounge conversion at roughly 1.30 dollars per pound. The company targets a gap in medtech trial diversity, where real patient cohorts are narrow and costly to recruit. Earlier work on digital twins of trial participants, including Unlearn's $50 million Series C in February 2024, shows that investors have backed similar models before. For AI builders in regulated sectors, the round signals that synthetic patient data is drawing venture money beyond drug development. Founders in healthcare should note that validation with regulators, not model quality alone, often sets how quickly such tools reach customers.